In just a decade, the drug-resistant fungal pathogen Candida auris (C. auris) has emerged as one of the most formidable threats to health care settings worldwide.

In 2019, state health officials released the first-ever list of hospitals and nursing homes in New York that treated patients harboring Candida auris, the deadly drug-resistant fungus. That list ...

Increased travel and migration are likely associated with recent outbreaks of Candida auris in New York and New Jersey, based on data from a study of simulated travel patterns. The spread of ...

Diseases caused by Candida are among the most common fungal infections worldwide. The new guideline was developed over four years by a team of more than one hundred experts from 35 countries.

Together with a team of international clinical researchers, Professor Dr Oliver A. Cornely and Dr Rosanne Sprute from University Hospital Cologne have published the new global guideline for the ...

Clinical cases of Candida auris jumped more than 50% from 2022 to 2023, according to state data reported to the CDC. In 2023, 4,514 clinical cases were reported across 36 states and Washington ...

Particular attention is paid to new challenges such as resistance to common antifungals and the increasing spread of Candida auris, a multi-resistant pathogen. "With this guideline, we have taken ...

Diseases caused by Candida are among the most common fungal infections worldwide / The new guideline was developed over four years by a team of more than one hundred experts from 35 countries, led by ...